Biomarkers for Prediction of Tumor Response to Radiotherapy

Trial Parameters

Brief Summary

This study aims to explore potential biomarkers for prediction of therapeutic outcomes in patients with solid tumors after radiotherapy

Eligibility Criteria

Inclusion Criteria: * Pathological proven diagnosis of solid tumors * Tumor accessible for biopsy during the course of radiotherapy or tumor samples could be obtained via surgery * Patient must provide study-specific informed consent prior to study entry Exclusion Criteria: * History of autoimmune diseases * History of immunotherapy * Prior radiation therapy that would result in overlap of planned radiation therapy fields * Will receive immunotherapy during the course of radiotherapy * Contraindications for biopsy, such as high bleeding risk

Related Trials